Is Alliança Saúde e Participações (BVMF:AALR3) Using Too Much Debt?
Jul 04
Have your own idea? Try our Stock Screener
Brazilian (BOVESPA) Healthcare Sector Analysis
UpdatedJul 15, 2025
DataAggregated Company Financials
Companies16
- 7D-2.9%
- 3M10.2%
- 1Y-10.0%
- YTD24.3%
Over the last 7 days, the Healthcare industry has dropped 4.1%, driven by Rede D'Or São Luiz declining 2.7%. Meanwhile, Alliança Saúde e Participações actually outperformed within the industry, gaining 16% in the last week. However, the industry is down 9.4% over the past year. Looking forward, earnings are forecast to grow by 30% annually.
Sector Valuation and Performance
Has the Brazilian Healthcare Sector valuation changed over the past few years?
| Date | Market Cap | Revenue | Earnings | PE | Absolute PE | PS |
|---|---|---|---|---|---|---|
| Tue, 15 Jul 2025 | R$134.2b | R$149.5b | R$2.0b | 11x | 65.8x | 0.9x |
| Thu, 12 Jun 2025 | R$141.4b | R$149.5b | R$2.0b | 10.6x | 69.4x | 0.9x |
| Sat, 10 May 2025 | R$133.3b | R$149.0b | R$2.2b | 10.7x | 61.3x | 0.9x |
| Mon, 07 Apr 2025 | R$118.7b | R$150.7b | R$3.6b | 10.3x | 33.2x | 0.8x |
| Wed, 05 Mar 2025 | R$115.0b | R$146.8b | R$4.7b | 10.7x | 24.5x | 0.8x |
| Fri, 31 Jan 2025 | R$114.1b | R$146.7b | R$4.7b | 11.5x | 24.4x | 0.8x |
| Sun, 29 Dec 2024 | R$109.7b | R$146.7b | R$4.7b | 11.5x | 23.5x | 0.7x |
| Tue, 26 Nov 2024 | R$128.2b | R$148.2b | R$5.2b | 13.7x | 24.4x | 0.9x |
| Thu, 24 Oct 2024 | R$141.9b | R$144.9b | R$4.4b | 11.3x | 32.2x | 1x |
| Sat, 21 Sep 2024 | R$153.7b | R$144.9b | R$4.4b | 11.2x | 34.9x | 1.1x |
| Mon, 19 Aug 2024 | R$153.8b | R$144.8b | R$4.3b | 11.9x | 35.9x | 1.1x |
| Wed, 17 Jul 2024 | R$148.7b | R$143.3b | R$4.2b | 11.9x | 35.7x | 1x |
| Fri, 14 Jun 2024 | R$137.0b | R$142.9b | R$4.2b | 11.3x | 32.7x | 1x |
| Sun, 12 May 2024 | R$150.4b | R$142.3b | R$3.8b | 12.3x | 39.5x | 1.1x |
| Tue, 09 Apr 2024 | R$141.3b | R$140.0b | R$3.2b | 12.5x | 44.6x | 1x |
| Thu, 07 Mar 2024 | R$143.4b | R$132.9b | R$2.7b | 14.6x | 52.8x | 1.1x |
| Sat, 03 Feb 2024 | R$150.7b | R$135.0b | R$2.9b | 16.7x | 52.3x | 1.1x |
| Mon, 01 Jan 2024 | R$169.9b | R$135.0b | R$2.9b | 21.2x | 58.9x | 1.3x |
| Wed, 29 Nov 2023 | R$160.1b | R$135.0b | R$2.9b | 19.4x | 55.5x | 1.2x |
| Fri, 27 Oct 2023 | R$144.6b | R$126.1b | R$2.7b | 18.3x | 52.6x | 1.1x |
| Sun, 24 Sep 2023 | R$162.1b | R$126.1b | R$2.7b | 19.5x | 59x | 1.3x |
| Tue, 22 Aug 2023 | R$177.8b | R$126.1b | R$2.7b | 20.2x | 64.7x | 1.4x |
| Thu, 20 Jul 2023 | R$183.5b | R$116.7b | R$2.8b | 16.5x | 65.1x | 1.6x |
| Sat, 17 Jun 2023 | R$182.9b | R$116.7b | R$2.8b | 16.9x | 64.6x | 1.6x |
| Mon, 15 May 2023 | R$148.4b | R$108.1b | R$2.9b | 17.4x | 50.3x | 1.4x |
| Wed, 12 Apr 2023 | R$136.6b | R$106.3b | R$3.3b | 14.6x | 41.1x | 1.3x |
| Fri, 10 Mar 2023 | R$138.0b | R$102.8b | R$3.8b | 14.7x | 36.5x | 1.3x |
| Sun, 05 Feb 2023 | R$173.6b | R$98.3b | R$4.2b | 15.5x | 41.6x | 1.8x |
| Tue, 03 Jan 2023 | R$163.7b | R$98.3b | R$4.2b | 15x | 39.3x | 1.7x |
| Thu, 01 Dec 2022 | R$170.4b | R$98.3b | R$4.2b | 16.1x | 40.9x | 1.7x |
| Sat, 29 Oct 2022 | R$191.4b | R$90.4b | R$4.6b | 16.8x | 41.6x | 2.1x |
| Mon, 26 Sep 2022 | R$207.7b | R$90.4b | R$4.6b | 16.7x | 45.2x | 2.3x |
| Wed, 24 Aug 2022 | R$198.7b | R$90.2b | R$4.5b | 14x | 44.4x | 2.2x |
| Fri, 22 Jul 2022 | R$176.5b | R$84.2b | R$5.2b | 13.1x | 33.7x | 2.1x |
Price to Earnings Ratio
33.7x
Current Industry PE
- Investors are optimistic on the Brazilian Healthcare industry, and appear confident in long term growth rates.
- The industry is trading at a PE ratio of 65.5x which is higher than its 3-year average PE of 45.0x.
- The 3-year average PS ratio of 1.3x is higher than the industry's current PS ratio of 0.89x.
Past Earnings Growth
- The earnings for companies in the Healthcare industry have declined 27% per year over the last three years.
- Meanwhile revenues for these companies have grown 21% per year.
- This means that although more sales are being generated, either the cost of doing business or the level of investment back into businesses has increased, which has decreased profits.
Industry Trends
Which industries have driven the changes within the Brazilian Healthcare sector?
| BR Market | -2.93% | |
| Healthcare | -2.89% | |
| Medical Equipment | -0.062% | |
| Biotech | -1.06% | |
| Pharma | -2.46% | |
| Healthcare Services | -3.02% | |
Industry PE
- Investors are most optimistic about the Healthcare Services industry which is trading above its 3-year average PE ratio of 97.2x.
- Analysts are expecting annual earnings growth of 29.7%, which is lower than the prior year's growth of 43.2% per year.
- Investors are most pessimistic about the Medical Equipment industry, although it looks like investor sentiment has improved given that it's trading above its 3-year average.
Forecasted Growth
- Analysts are most optimistic on the Pharma industry, expecting annual earnings growth of 32% over the next 5 years.
- This is better than its past earnings decline of 52% per year.
- In contrast, the Biotech industry is expected to see its earnings grow by 8.6% per year over the next few years.
Top Stock Gainers and Losers
Which companies have driven the market over the last 7 days?
| Company | Last Price | 7D | 1Y | Valuation | |
|---|---|---|---|---|---|
| AALR3 Alliança Saúde e Participações | R$5.21 | 12.0% +R$66.2m | -58.2% | PS0.5x | |
| ODPV3 Odontoprev | R$11.34 | 0.4% +R$27.3m | -7.0% | PE11x | |
| PFRM3 Profarma Distribuidora de Produtos Farmacêuticos | R$8.24 | 1.9% +R$18.4m | 55.5% | PE8.1x | |
| BLAU3 Blau Farmacêutica | R$12.98 | 0.2% +R$5.3m | 5.6% | PE8.6x | |
| MATD3 Hospital Mater Dei | R$4.48 | 0.2% +R$3.4m | -7.2% | PS0.7x |
